Related Experiment Videos
Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy
Sho-ichi Yamagishi1, Tsutomu Imaizumi
1Department of Internal Medicine III, Kurume University School of Medicine, Japan. shoichi@med.kurume-u.ac.jp
Insights
Diabetic vascular complications, a major cause of diabetes-related morbidity and mortality, are driven by chronic hyperglycemia. Understanding these molecular mechanisms is key to developing new therapies for diabetes complications.
Area of Science:
- Endocrinology
- Vascular Biology
- Diabetology
Background:
- Diabetic vascular complications contribute significantly to end-stage renal failure, blindness, neuropathy, and atherosclerosis.
- These complications lead to substantial disability and mortality in diabetic patients.
- While intensive glucose control benefits microvascular outcomes, macrovascular complications involve insulin resistance and postprandial hyperglycemia.
Purpose of the Study:
- To summarize the molecular mechanisms underlying diabetic vascular complications.
- To explore potential therapeutic interventions for preventing these disorders, even when hyperglycemia is difficult to control.
Main Methods:
- Review of molecular mechanisms initiated by chronic hyperglycemia.
- Analysis of pathways including advanced glycation end products, protein kinase C, polyol pathway, and reactive oxygen species.
- Examination of the role of vascular inflammation, gene expression, and cellular activation.
Main Results:
- Chronic hyperglycemia initiates vascular complications through multiple molecular pathways.
- These pathways regulate vascular inflammation, alter growth factor and cytokine expression, and activate platelets and macrophages.
- High glucose plays a central role in the development and progression of diabetic vascular complications.
Conclusions:
- Understanding the molecular basis of diabetic vascular complications is crucial.
- Targeting these mechanisms may offer therapeutic strategies to prevent or mitigate complications.
- Novel interventions are needed to manage hyperglycemia and its vascular consequences effectively.
Abstract:
Diabetic vascular complication is a leading cause of end-stage renal failure, acquired blindness, a variety of neuropathies and accelerated atherosclerosis, which could account for disabilities and high mortality rates in patients with diabetes. Recent large prospective clinical studies have shown that intensive glucose control reduces effectively microvascular complications among patients with diabetes, and insulin resistance and postprandial hyperglycemia seem to be involved in diabetic macrovascular complications. Chronic hyperglycemia is a major initiator of diabetic vascular complications. Indeed, high glucose, via various mechanisms such as increased production of advanced glycation end products, activation of protein kinase C, stimulation of the polyol pathway and enhanced reactive oxygen species generation, regulates vascular inflammation, altered gene expression of growth factors and cytokines, and platelet and macrophage activation, thus playing a central role in the development and progression of diabetic vascular complications. This article summarizes the molecular mechanisms of diabetic vascular complications and the potential therapeutic interventions that may prevent these disorders even in the presence of hyperglycemia, control of which is often difficult with current therapeutic options.
Related Concept Videos
Diabetic Retinopathy
Diabetic Neuropathy
Diabetic Foot Ulcer
Type II Diabetes II: Pathophysiology
Complications of Diabetes Mellitus
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...